Exact Sciences Corp EXAS:NASDAQ

Last Price$42.71NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/12/22

Today's Change0(0.00%)
Bid (Size)$42.80 (5)
Ask (Size)$43.34 (1)
Day Low / HighN/A - N/A
Volume2.4 M
 

View Biotechnology IndustryPeer Comparison as of 08/12/2022

 

Exact Sciences Corp ( NASDAQ )

Price: $42.71
Change: +0.35 (0.83%)
Volume: 2.4 M
4:00PM ET 8/12/2022
 
 

Halozyme Therapeutics Inc ( NASDAQ )

Price: $43.14
Change: -0.22 (0.51%)
Volume: 1.1 M
4:00PM ET 8/12/2022
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Arrowhead Pharmaceuticals Inc ( NASDAQ )

Price: $47.29
Change: +1.66 (3.64%)
Volume: 604.0 K
4:00PM ET 8/12/2022
 
 

Mirati Therapeutics Inc ( NASDAQ )

Price: $86.37
Change: +5.92 (7.36%)
Volume: 672.2 K
4:00PM ET 8/12/2022
 

Read more news Recent News

Research Alert: CFRA Keeps Buy Opinion On Shares Of Exact Sciences Corporation
10:00AM ET 8/04/2022 MT Newswires

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...

--Craig Hallum Lowers Exact Sciences Price Target to $60 From $81, Maintains Buy Rating
9:52AM ET 8/03/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Baird Adjusts Price Target on Exact Sciences to $75 From $90, Keeps Outperform Rating
8:49AM ET 8/03/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--BTIG Adjusts Price Target on Exact Sciences to $70 From $100, Reiterates Buy Rating
8:49AM ET 8/03/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

View all Commentary and Analysis

Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q2 2022 Results - Earnings Call Transcript
7:16PM ET 8/02/2022 Seeking Alpha

Veracyte: Fading The Rally
3:58PM ET 7/15/2022 Seeking Alpha

Tracking Cathie Wood's ARK Invest 13F Portfolio - Q2 2022 Update
9:28PM ET 7/14/2022 Seeking Alpha

Time To Board The ARKK
2:53AM ET 7/08/2022 Seeking Alpha

Company Profile

Business DescriptionEXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI. View company web site for more details
Address5505 Endeavor Lane
Madison, Wisconsin 53719
Phone+1.608.284.5700
Number of Employees1,977
Recent SEC Filing08/08/20223
Chairman, President & Chief Executive OfficerKevin T. Conroy
Executive VP, Chief Operating & Financial OfficerJeffrey Thomas Elliott
Senior VP-Clinical & Regulatory AffairsSandra Statz
Chief Information OfficerGary Frings

Company Highlights

Price Open$42.65
Previous Close$42.36
52 Week Range$35.34 - 108.99
Market Capitalization$7.6 B
Shares Outstanding177.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/01/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$4.13
Beta vs. S&P 500N/A
Revenue$454.5 M
Net Profit Margin-37.89%
Return on Equity-22.07%

Analyst Ratings as of 08/03/2022

Buy
13
Overweight
4
Hold
2
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset